Posts

Posted on

IIROC Trade Resumption – SONA

Canada NewsWire

VANCOUVER, BC, Dec. 31, 2020 /CNW/ – Trading resumes in:

Company: Sona Nanotech Inc.

CSE Symbol: SONA

All Issues: Yes

Resumption (ET): 9:45 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC)

Posted on

IIROC Trading Halt – ITM

Canada NewsWire

VANCOUVER, BC, Dec. 31, 2020 /CNW/ – The following issues have been halted by IIROC:

Company: Intema Solutions Inc.

TSX-Venture Symbol: ITM

All Issues: Yes

Reason: Pending Clarification of News

Halt Time (ET): 9:07 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Posted on

Ridgewood Canadian Investment Grade Bond Fund Announces Estimated Distribution Rate for First Quarter

Canada NewsWire

TSX Symbol: RIB.UN

TORONTO, Dec. 31, 2020 /CNW/ – Ridgewood Canadian Investment Grade Bond Fund (the “Fund“) is pleased to announce the estimated distributions of the Fund for the first quarter of 2021 as follows:


Estimated Payable Date


Estimated Distribution Amount per Unit

February 15, 2021

$0.0530

March 15, 2021

$0.0530

April 15, 2021

$0.0530

This distribution rate equates to an annualized distribution rate of 5.30% on an initial subscription price of $12.00 per unit.  Details of each distribution, including the record and payment date, will be confirmed at the time of the declaration of the distribution.

About Ridgewood Canadian Investment Grade Bond Fund:

The Fund will seek to achieve the following investment objectives: (i) to provide unitholders with monthly cash distributions targeted to be 5.3% per annum on the original issue price of $12.00 per unit; and (ii) to maximize total returns for unitholders while preserving capital in the long term.

About Ridgewood Capital Asset Management Inc.:

Ridgewood is an independent investment manager that manages approximately $1.3 billion in assets for a diversified client base of high net worth individuals, foundations/endowments, First Nation mandates and institutional accounts, of which approximately $1.0 billion is invested in fixed income assets.

This press release contains forward-looking information. The forward-looking information contained in this press release is based on historical information concerning the income generated by the portfolio of the Fund. Actual future results, including the amount of distributions paid by the Fund, may differ from the estimated monthly distribution amount. Specifically, the income from which distributions are paid may vary significantly due to: changes in portfolio composition; changes in income received from securities included in the Fund’s portfolio from time to time; general economic and stock market conditions including changes in interest rates; and the level of borrowing by the Fund.  The risks, uncertainties and other factors that could influence actual results are described under “Risk Factors” in the Fund’s prospectus dated December 8, 2011 and other documents filed by the Fund with the Canadian securities regulatory authorities. The forward-looking
information contained in this press release constitutes the Fund’s current estimate, as of the date of this press release, with respect to the matters covered hereby. Investors and others should not assume that any forward-looking statement contained in this press release represents the Fund’s estimate as of any date other than the date of this press release.

SOURCE Ridgewood Canadian Investment Grade Bond Fund

Posted on

Terreno Realty Corporation Acquires Property in Tukwila, WA for $6.6 Million

Terreno Realty Corporation Acquires Property in Tukwila, WA for $6.6 Million

SAN FRANCISCO–(BUSINESS WIRE)–Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, acquired an industrial property in Tukwila, Washington on December 30, 2020 for a purchase price of approximately $6.6 million.

The 2.1-acre improved land parcel at 12119 East Marginal Way S is adjacent to State Routes 99 and 599 and Interstate 5. The property is 100% leased to one tenant and the estimated stabilized cap rate is 4.6%.

Estimated stabilized cap rates are calculated as annualized cash basis net operating income stabilized to market occupancy (generally 95%) divided by total acquisition cost. Total acquisition cost includes the initial purchase price, the effects of marking assumed debt to market, buyer’s due diligence and closing costs, estimated near-term capital expenditures and leasing costs necessary to achieve stabilization.

Terreno Realty Corporation acquires, owns and operates industrial real estate in six major coastal U.S. markets: Los Angeles; Northern New Jersey/New York City; San Francisco Bay Area; Seattle; Miami; and Washington, D.C.

Additional information about Terreno Realty Corporation is available on the company’s web site at www.terreno.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. We caution investors that forward-looking statements are based on management’s beliefs and on assumptions made by, and information currently available to, management. When used, the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “project,” “result,” “should,” “will,” “seek,” “target,” “see,” “likely,” “position,” “opportunity,” “outlook,” “potential,” “enthusiastic,” “future” and similar expressions which do not relate solely to historical matters are intended to identify forward-looking statements. These statements are subject to risks, uncertainties, and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties, and factors that are beyond our control, including risks related to our ability to meet our estimated forecasts related to stabilized cap rates, the impact of the COVID-19 pandemic on our business, our tenants and the national and local economies, and those risk factors contained in our Annual Report on Form 10-K for the year ended December 31, 2019 and our other public filings. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated, or projected. We expressly disclaim any responsibility to update our forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on results and trends at the time they are made, to anticipate future results or trends.

Jaime Cannon

415-655-4580

KEYWORDS: California Washington United States North America

INDUSTRY KEYWORDS: Other Construction & Property Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo
Posted on

Wolters Kluwer divests French legal notices business line

 Wolters Kluwer divests French legal notices business line

DECEMBER 31, 2020 –
Wolters Kluwer Legal & Regulatory announces that it has signed and completed the divestment of its French legal notices business, Annonces & Formalités Légales, to Médialex, part of Sipa-Ouest-France Group.

Annonces & Formalités Légales, which has 34 full-time employees, supports the publication of legal notices and announcements for businesses in France.

The divestment is consistent with the strategy of Wolters Kluwer Legal & Regulatory to focus on professional information and software solutions in core legal markets. 

 

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide.

The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Media                                                                              Investors/Analysts

Gerbert van Genderen Stort                                            Meg Geldens
Corporate Communications                                             Investor Relations
t + 31 172 641 230                                                           t + 31 172 641 407
[email protected]                       [email protected]

Forward-looking Statements and Other Important Legal Information

This report contains forward-looking statements. These statements may be identified by words such as “expect”, “should”, “could”, “shall” and similar expressions. Wolters Kluwer cautions
that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer’s businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Attachment



Posted on

US Department of Agriculture Selects Draganfly Commander Drone

Los Angeles, CA, Dec. 31, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce that the US Department of Agriculture has selected the use of the Draganfly Commander drones to do phenotyping and other related data collection and analysis.

The Draganfly Commander Ag-Pro model is a turn-key UAV package providing extended flight times, high level of data resolutions and accuracy and the utmost data security.

Draganfly drones are important within the agriculture industry as they support evidence-based crop, health, planning and spatial data collection. These tools and technologies can provide valuable data that can then be used to influence policies and decisions.

In light of the US Department of Commerce and the Bureau of Industry and Security having added several Chinese drone manufacturers and chip makers to the entity list with restricted access to key enabling US technologies, Draganfly believes that its trusted North American manufacturing and security is the new benchmark for governmental and private organizations.

The North America UAV market, according to Global Market Insights, recorded a valuation of USD 1.7 billion in 2017, and is likely to exceed USD 7 billion by 2024.

“The growing use of UAVs within the US Department of Agriculture for diverse applications are fueling the need for our drones,” said Cameron Chell, CEO of Draganfly. “Draganfly is incredibly honored to be working with the Department of Agriculture and looking forward to serving their department on future projects.”

Draganfly is the oldest commercial drone manufacturer in North America and is credited as the world’s first small unmanned aircraft system (sUAS) to save a first human life in a search and rescue operation and this drone is currently on display at the Smithsonian’s National Air and Space Museum.

About Draganfly

Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge software and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first- class services to its customers around the world with the goal of saving time, money, and lives.

For more information on Draganfly, please visit us at www.draganfly.com.
For additional investor information visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/ draganfly-inc

Media Contact
Arian Hopkins
email: [email protected]

Company Contact
Email: [email protected]

Forward-Looking Statements

This release contains certain “forward looking statements” and certain “forward-looking ‎‎‎‎‎information” as defined under applicable Canadian securities laws. Forward-looking statements ‎‎‎‎‎and information can generally be identified by the use of forward-looking terminology such as ‎‎‎‎‎‎“may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar ‎‎‎‎‎terminology. Forward-looking statements and information are based on forecasts of future ‎‎‎‎‎results, estimates of amounts not yet determinable and assumptions that, while believed by ‎‎‎‎‎management to be reasonable, are inherently subject to significant business, economic and ‎‎‎‎‎competitive uncertainties and contingencies. Forward-looking statements include, but are not ‎‎‎‎‎limited to, statements with respect to the US Department of Agriculture use of the Draganfly Commander drones to manage crop health. Forward-‎‎‎‎looking statements and information are subject ‎to various known and unknown risks and ‎‎‎‎uncertainties, many of which are beyond the ability of ‎the Company to control or predict, that ‎‎‎‎may cause the Company’s actual results, performance or ‎achievements to be materially different ‎‎‎‎from those expressed or implied thereby, and are ‎developed based on assumptions about such ‎‎‎‎risks, uncertainties and other factors set out here ‎in, including but not limited to: the potential ‎‎‎‎impact of epidemics, pandemics or other public ‎health crises, including the current outbreak of ‎‎‎‎the novel coronavirus known as COVID-19 on the ‎Company’s business, operations and financial ‎‎‎‎condition, the successful integration of ‎technology, the inherent risks involved in the general ‎‎‎‎securities markets; uncertainties relating to ‎the availability and costs of financing needed in the ‎‎‎‎future; the inherent uncertainty of cost ‎estimates and the potential for unexpected costs and ‎‎‎‎expenses, currency fluctuations; regulatory ‎restrictions, liability, competition, loss of key ‎‎‎‎employees and other related risks and uncertainties ‎disclosed under the heading “Risk Factors“ ‎‎‎‎in the Company’s most recent filings filed with ‎securities regulators in Canada on the SEDAR ‎‎‎‎website at www.sedar.com. The Company ‎undertakes no obligation to update forward-looking ‎‎‎‎information except as required by applicable ‎law. Such forward-looking information represents ‎‎‎‎managements’ best judgment based on ‎information currently available. No forward-looking ‎‎‎‎statement can be guaranteed and actual ‎future results may vary materially. Accordingly, readers ‎‎‎‎are advised not to place undue reliance ‎on forward-looking statements or information.‎



Posted on

Moderna Confirms 40 Million COVID-19 Vaccine Dose Supply Agreement with the Government of the Republic of Korea

Moderna Confirms 40 Million COVID-19 Vaccine Dose Supply Agreement with the Government of the Republic of Korea

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today confirmed the Company has entered into a supply agreement with the government of the Republic of Korea to provide 40 million doses of the Moderna COVID-19 Vaccine to support the government’s aim of providing vaccines to the public as soon as possible. Under the terms of the proposed agreement, deliveries would begin in May 2021. The Moderna COVID-19 Vaccine is not currently approved for use in South Korea, and the Company will work with regulators to pursue the necessary approvals prior to distribution.

“We thank the Republic of Korea for partnering with us to bring the Moderna COVID-19 Vaccine to South Korea. The government has moved very swiftly to get this done in the face of the pandemic. We believe this supply agreement is an important step towards building a long-lasting future collaboration between Moderna and the Republic of Korea,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We look forward to continuing discussions with government officials and to building a stronger scientific and clinical presence of Moderna in South Korea.”

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. The company’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, and BARDA. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.

Authorized Use

The Moderna COVID-19 Vaccine has not been approved or licensed by U.S. Food and Drug Administration (FDA), but FDA has authorized the vaccine for emergency use in individuals 18 years of age and older.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding: the Company’s development of a vaccine against the novel coronavirus, and the potential provision of the Moderna COVID-19 Vaccine to the government of South Korea. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could”, “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others: the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response technology in use by Moderna is still being developed and implemented; the safety, tolerability and efficacy profile of the Moderna COVID-19 Vaccine observed to date may change adversely in ongoing analyses of trial data or subsequent to commercialization; despite having ongoing interactions with the FDA or other regulatory agencies, the FDA or such other regulatory agencies may not agree with the Company’s regulatory approval strategies, components of our filings, such as clinical trial designs, conduct and methodologies, or the sufficiency of data submitted; Moderna may encounter delays in meeting manufacturing or supply timelines or disruptions in its distribution plans for the Moderna COVID-19 Vaccine; whether and when any biologics license applications and/or emergency use authorization applications may be filed and ultimately approved by regulatory authorities; potential adverse impacts due to the global COVID-19 pandemic such as delays in regulatory review, manufacturing and clinical trials, supply chain interruptions, adverse effects on healthcare systems and disruption of the global economy; and those other risks and uncertainties described under the heading “Risk Factors” in Moderna’s most recent Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (SEC) and in subsequent filings made by Moderna with the SEC, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date hereof.

Moderna


Media:

Colleen Hussey

Director, Corporate Communications

617-335-1374

[email protected]

Investors:

Lavina Talukdar

Senior Vice President & Head of Investor Relations

617-209-5834

[email protected]

KEYWORDS: Massachusetts South Korea United States North America Asia Pacific

INDUSTRY KEYWORDS: Research Infectious Diseases FDA Cardiology Biotechnology Health Pharmaceutical Science Oncology

MEDIA:

Logo
Logo
Posted on

IIROC Trade Resumption – OREA

Canada NewsWire

TORONTO, Dec. 31, 2020 /CNW/ – Trading resumes in:

Company: Orea Mining Corp.

TSX Symbol: OREA

All Issues: Yes

Resumption (ET): 9:30 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Posted on

Central Garden & Pet To Acquire Green Garden

Central Garden & Pet To Acquire Green Garden

Acquisition Builds Further Scale in Garden Segment with Entry into Attractive Adjacent Category

WALNUT CREEK, Calif.–(BUSINESS WIRE)–
Central Garden & Pet (NASDAQ: CENT, CENTA) (“Central”), a market leader in the Garden and Pet industries, announced today that it has signed an agreement to acquire Green Garden Products (“Green Garden”), previously known as Plantation Products, for $532 million from private equity firm Freeman Spogli & Co and other shareholders. Green Garden, headquartered in Norton, Mass., is a leading provider of vegetable, herb and flower seed packets, seed starters and plant nutrients in North America, shipping over 250 million seed packets annually. The addition of Green Garden’s leading brands will expand the Central portfolio into an attractive adjacent category and strengthen the Company’s relationship with major retailers.

“We are thrilled to welcome Green Garden into the Central Garden & Pet team upon closing,” said Tim Cofer, CEO of Central. “Our new Central to Home strategy is focused on building further scale in our two operating segments and meeting consumer and customer needs. Adding Green Garden’s well-known and trusted seed and seed starting brands for vegetables, herbs and flower gardens will expand our portfolio into an attractive adjacent garden category and will strengthen our footprint with key retail customers. Moreover, we expect to leverage our strong merchandising, brand building and digital capabilities to grow sales for both Central and our retail partners.”

Established in 1980, Green Garden currently employs over 180 full-time employees with a deep sense of pride and responsibility to carry on the traditions of its brands many of which were founded in the mid-1800s. The company’s portfolio of well-known and trusted brands includes Ferry-Morse® Home Gardening, Jiffy® Seed Starting, SUPERthrive® Plant Nutrients, Livingston® Seeds, Jiffy Hydro® Hydroponics, McKenzie® Seed, American Seed® and NK Lawn and Garden®. With production and distribution facilities in Ohio, California and Manitoba, Canada, Green Garden distributes more than 3,500 product SKUs to a network of over 70,000 retail locations across the home center, mass merchant, farm and independent, dollar store, and distributor/co-op channels in the United States and Canada as well as through its owned and operated websites.

“We are excited to bring our existing seed and seed starter business to Central Garden & Pet,” said Michael Pietrasiewicz, President and CEO of Green Garden. “Our quest for innovative ideas which leads us to develop new products that help home gardeners and outdoor hobbyists enjoy their passion and be more successful coupled with Central’s expertise in the lawn and garden segment will be key to grow our business further.”

The transaction is expected to close in the second quarter of fiscal 2021, subject to customary closing conditions, including regulatory approval. Central senior management will provide more details on its recent acquisitions at the Company’s first quarter fiscal 2021 earnings call.

William Blair served as financial advisor to Green Garden and Morgan, Lewis & Bockius LLP acted as the legal advisor. Orrick, Herrington & Sutcliffe LLP served as the legal advisor to Central.

About Central Garden & Pet

Central Garden & Pet (NASDAQ: CENT, CENTA) understands that home is central to life and has proudly nurtured happy and healthy homes for over 40 years. With 2020 net sales of $2.7 billion, Central is on a mission to lead the future of the pet and garden industries. The Company’s innovative and trusted products are dedicated to help lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a leading portfolio of more than 65 high-quality brands including Pennington, Nylabone, Kaytee, Amdro and Aqueon, strong manufacturing and distribution capabilities and a passionate, entrepreneurial growth culture. Central Garden & Pet is based in Walnut Creek, California and has over 6,300 employees across North America and Europe. For additional information about Central, please visit the Company’s website at www.central.com.

About Green Garden Products

Headquartered in Norton, Massachusetts, Green Garden Products is the leading supplier of seed packets and seed starter products for flower and vegetable gardens in North America, as well an emerging participant in the specialty soil category. The Company distributes over 3,500 SKUs under the Ferry-Morse, American Seed, Livingston Seed, McKenzie, NK Lawn & Garden, Jiffy, SUPERthrive, Dyna-Gro and Seeds of Change brand names to a network of over 70,000 retail locations across the home center, mass merchant, farm and independent, dollar store, and distributor/co-op channels. The Company provides its retail customers with best-in-class category management services including SKU selection, packaging and displays, in-store merchandising services, and logistical solutions. In addition to its headquarters in Massachusetts, the Company maintains production and distribution facilities in Ohio, California and Manitoba. For additional information about Green Garden Products, please visit the Company’s website at www.greengarden.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements, other than statements of historical fact, could be deemed forward-looking statements. Statements in this press release concerning Central’s business, strategy and focus; our agreement to acquire Green Garden; the ability to build scale in the seed category and add key digital capabilities; and our overall future prospects are forward-looking statements that involve a number of uncertainties and risks. Actual results or events could differ materially from those anticipated in those forward-looking statements as a result of several factors, including, without limitation, our ability to close the acquisition in a timely basis or at all, our ability to integrate the acquired company, potential benefits of the transaction to Central and our customers, and other factors listed in our annual report on Form 10-K filed with the Securities and Exchange Commission. All statements made in this press release are made only as of the date of this press release. Central undertakes no obligation to update the information in this press release in the event facts or circumstances subsequently change after the date of this press release.

Investor Relations Contact

Friederike Edelmann

(925) 412-6726

[email protected]

Media Relations Contact

Liz Nunan

(925) 878-9465

[email protected]

KEYWORDS: California Massachusetts United States North America

INDUSTRY KEYWORDS: Construction & Property Other Retail Pets Landscape Home Goods Consumer Retail Agriculture Natural Resources

MEDIA:

Logo
Logo
Posted on

Cushing® Asset Management and Swank Capital Announce Rebalancing of the Cushing® MLP High Income Index

PR Newswire

DALLAS, Dec. 31, 2020 /PRNewswire/ — Cushing® Asset Management, LP, and Swank Capital, LLC, announce today the upcoming rebalancing of The Cushing® MLP High Income Index (the “Index”) as part of normal index operations. After the markets close on January 8, 2021, the 30 constituents of the Index will be rebalanced, and the following changes will become effective on January 11, 2021:

Constituents added:
BP Midstream Partners LP (NYSE: BPMP)
Equitrans Midstream Corporation (NYSE: ETRN)

Constituents removed:
Enviva Partners, LP (NYSE: EVA)
NGL Energy Partners LP (NYSE: NGL)

ABOUT THE CUSHING® MLP HIGH INCOME INDEX

The Cushing® MLP High Income Index provides a benchmark that is designed to track the performance of 30 higher-yielding publicly traded midstream energy infrastructure companies, including master limited partnerships (MLPs) and non-MLP energy midstream corporations (each, a “Midstream Company” and collectively, “Midstream Companies”). Constituents are chosen according to a three-tiered proprietary weighting system developed by Cushing® Asset Management, LP. The Cushing® MLP High Income Index is calculated by S&P Dow Jones Indices and reported on a real-time basis under the Bloomberg ticker “MLPY”.

ABOUT CUSHING® ASSET MANAGEMENT AND SWANK CAPITAL

Cushing
® Asset Management, LP (“Cushing“), a subsidiary of Swank Capital, LLC, is an SEC-registered investment adviser headquartered in Dallas, Texas. Cushing serves as investment adviser to affiliated funds and managed accounts, providing active management in markets where inefficiencies exist.

Cushing is also dedicated to serving the needs of MLP and energy income investors by sponsoring a variety of industry benchmarks, including The Cushing® 30 MLP Index (Bloomberg Ticker: MLPX) and The Cushing® MLP Market Cap Index (Bloomberg Ticker: CMCI). For more information, please visit http://www.cushingasset.com/indices.

For additional information contact:
Jon Abel
214-692-6334
http://www.cushingasset.com

The Cushing® MLP High Income Index (the “Index”) is the exclusive property of Swank Capital, LLC, and Cushing® Asset Management, LP, which have contracted with S&P Opco, LLC (a subsidiary of S&P Dow Jones Indices LLC) (“S&P Dow Jones Indices”) to maintain and calculate the Index. S&P® is a registered trademark of Standard & Poor’s Financial Services LLC (“SPFS”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”); and these trademarks have been licensed to S&P Dow Jones Indices. “Calculated by S&P Dow Jones Indices” and its related stylized mark(s) have been licensed for use by Cushing® Asset Management, LP. Neither S&P Dow Jones Indices, SPFS, Dow Jones S&P nor any of their affiliates sponsor and promote the Index and none shall be liable for any errors or omissions in calculating the Index.

Cision View original content:http://www.prnewswire.com/news-releases/cushing-asset-management-and-swank-capital-announce-rebalancing-of-the-cushing-mlp-high-income-index-301199542.html

SOURCE Cushing® Asset Management, LP and Swank Capital, LLC